Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 5899 clinical trials
Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer

This phase II study investigates how well radium-223 works in treating patients with castration-resistant prostate cancer than has spread to the bones (bone metastases). Prostate cancer is the most common cancer in men and the second leading cause of cancer death.

metastasis
metastatic malignant neoplasm
stage iva prostate cancer ajcc v8
dna damage
metastatic castration-resistant prostate cancer
  • 0 views
  • 19 Feb, 2024
Cancer Therapy Effects on the Heart

Anthracycline chemotherapies (e.g. doxorubicin, daunorubicin) is commonly given to treat pediatric cancer, and carries a risk of cardiotoxicity. Over the long term, children who receive these therapies have an increased risk of heart failure and early cardiovascular death.

anthracycline
metastasis
cancer treatment
daunorubicin
pediatric
  • 0 views
  • 19 Feb, 2024
Post-Marketing Follow-Up of Long-term Type Ureteral Stent Set

Although there are several reports regarding the effectiveness of long-term ureteral stents for malignancy ureteral obstruction, ureteral stricture and urolithiasis, the experience is limited about the long-term ureteral stents made by Taiwan.

  • 0 views
  • 19 Feb, 2024
Patient-Derived Xenografts to Reduce Cancer Health Disparities

This trial establishes patient-derived cancer xenografts in addressing cancer health and treatment disparities that disproportionately affect racial/ethnic minorities. Understanding the genetic and response differences among racial/ethnic minorities may help researchers enhance the precision of therapeutic treatments.

gastric cancer
lung cancer
biospecimen collection
cancer
liver cancer
  • 0 views
  • 19 Feb, 2024
Immunotherapy in Lung Cancer: Treatment After IO Cessation.

Immunotherapy is now a standard of care for first-line and eventually salvage therapy in patients with stage IV NSCLC and as adjuvant after RT-CT for stage III NSCLC. The aim of the study is determining the therapeutic landscape and the reason for immunotherapy cessation.

salvage therapy
adjuvant
small cell lung cancer
carcinoma of the cervix
chemoradiotherapy
  • 0 views
  • 19 Feb, 2024
Early Diagnosis of Upper Digestive Tract Disease

Upper digestive tract cancer (UDC) is a major disease burden worldwide encompassing all cancers involving the digestive tract (from oral cavity to duodenum).

early diagnosis
breakdown
early detection
gastrointestinal disorder
mass spectrometry
  • 4 views
  • 19 Feb, 2024
RadioPathomics Artificial Intelligence Model to Predict nCRT Response in Locally Advanced Rectal Cancer

In this study, investigators utilize a radiopathomics integrated Artificial Intelligence (AI) supportive system to predict tumor response to neoadjuvant chemoradiotherapy (nCRT) before its administration for patients with locally advanced rectal cancer (LARC).

adjuvant
metastasis
chemoradiotherapy
adenocarcinoma of rectum
adjuvant therapy
  • 0 views
  • 19 Feb, 2024
Survival Analysis of Frail Patients With Localised Colorectal Cancer

The purpose of this study is to analyse the survival of frail patients with localized colorectal cancer who undergo surgical treatment in comparison with those with palliative treatment

colorectal cancer
cancer
  • 0 views
  • 19 Feb, 2024
Radiomics-based Artificial Intelligence System to Predict Neoadjuvant Treatment Response in Rectal Cancer

In this study, investigators utilize a radiomics prediction model to predict the tumor response to neoadjuvant chemoradiotherapy (nCRT) before the nCRT is administered for patients with locally advanced rectal cancer (LARC).

adjuvant
metastasis
chemoradiotherapy
adenocarcinoma of rectum
adjuvant therapy
  • 0 views
  • 19 Feb, 2024
A Single-cell Transcriptome Study in Patients With Non-Hodgkin's Lymphoma

Using single-cell RNA sequencing, this study will explore the heterogeneity of lymphoma inside and outside the lymph node, identify tumor specific molecular markers and cell subgroups, explore the differences in tumor microenvironment composition, and provide a basis for diagnosis and precision treatment.

lymphoma
hodgkin's disease
non-hodgkin lymphoma
  • 0 views
  • 19 Feb, 2024